Business Description
Guardian Pharmacy Services Inc
NAICS : 623110
SIC : 5912
ISIN : US40145W1018
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | -1.2 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 6.91 | |||||
Beneish M-Score | -3.81 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.4 | |||||
3-Year EBITDA Growth Rate | 6.2 | |||||
3-Year EPS without NRI Growth Rate | 5.2 | |||||
3-Year FCF Growth Rate | 8.3 | |||||
3-Year Book Growth Rate | -9.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.78 | |||||
9-Day RSI | 65.53 | |||||
14-Day RSI | 66.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 20.5 | |||||
Days Sales Outstanding | 35.06 | |||||
Days Payable | 49.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.89 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.74 | |||||
Operating Margin % | -8.05 | |||||
Net Margin % | -9.77 | |||||
FCF Margin % | 0.5 | |||||
ROE % | -151.1 | |||||
ROA % | -28.39 | |||||
ROIC % | -34.04 | |||||
3-Year ROIIC % | 18.53 | |||||
ROC (Joel Greenblatt) % | -87.38 | |||||
ROCE % | -46.67 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.74 | |||||
PB Ratio | 12.46 | |||||
Price-to-Tangible-Book | 35.96 | |||||
Price-to-Free-Cash-Flow | 341.62 | |||||
Price-to-Operating-Cash-Flow | 125.62 | |||||
EV-to-EBIT | -21.4 | |||||
EV-to-EBITDA | -24.71 | |||||
EV-to-Revenue | 1.73 | |||||
EV-to-FCF | 344.26 | |||||
Price-to-Peter-Lynch-Fair-Value | 7.03 | |||||
Earnings Yield (Greenblatt) % | -4.67 | |||||
FCF Yield % | 0.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:GRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guardian Pharmacy Services Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 895.497 | ||
EPS (TTM) ($) | -1.432 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | - | ||
14-Day RSI | 66.18 | ||
14-Day ATR ($) | 1.34702 | ||
20-Day SMA ($) | 23.5715 | ||
12-1 Month Momentum % | - | ||
52-Week Range ($) | 14.16 - 25.735 | ||
Shares Outstanding (Mil) | 63.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guardian Pharmacy Services Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guardian Pharmacy Services Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Guardian Pharmacy Services Inc Frequently Asked Questions
What is Guardian Pharmacy Services Inc(GRDN)'s stock price today?
When is next earnings date of Guardian Pharmacy Services Inc(GRDN)?
Does Guardian Pharmacy Services Inc(GRDN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |